Wall Street Sees Woodcock Commissionership As Positive for Aducanumab, But Eyes Should Be On Cavazzoni
Pink Sheet: Informa Pharma Intelligence – January 29, 2020 Nancy [...]
Woodcock Faces Maze Of Rules To Become Commissioner Nominee
Pink Sheet: Informa Pharma Intelligence – January 21, 2020 Nancy [...]
Biden’s FDA Commissioner Playbook: Build On COVID Innovations To Modernize Agency
Pink Sheet: Informa Pharma Intelligence – January 6, 2020 Nancy [...]
States May Tighten Medicaid Rates Amid Pandemic
AIS Health Daily – August 3, 2020 Catalyst’s Jeff Myers [...]
How to Work with the US FDA When You Can’t Meet with Them
On July 23rd, 2020 during the Informa Pharma Intelligence COVID-19 [...]
Catalyst to Moderate a Panel at the American Society of Gene & Cell Therapy Policy Summit
Catalyst Founder and President, Nancy Myers, will be moderating a [...]
What Does the Future Hold for Medicaid, and How Will COVID-19 Impact the Public Payor Space in the Near Term
On June 16th at the Mostly Medicaid 2020 Summer Virtual [...]
Catalyst to Speak on COVID-19 Lessons Learned for Engaging FDA
Catalyst Healthcare Consulting will be speaking at an Informa Pharma [...]
Gene Therapy CMC Constriction Points and Ideas for Solutions – A Catalyst Moderated Panel at the DIA 2020 Annual Meeting
On June 15th at the DIA (Virtual) Annual Meeting, Catalyst’s [...]
Hahn Pledges FDA Independence While Maintaining Role On Warp Speed
In the Pink Sheet, Catalyst's Nancy Myers discusses the Administration's [...]